Active

KC PHARMA

Switched

BE0479334705

Rechtspersoon Private limited company 1 establishment

Leeuwerikheide 86, 2400 Mol Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Active for

23 year, 7 months

Financials

Financial year 2025

Gross margin

€ 158,741

▲ 428% vs 2024

Profit

Growing

€ 115,605

▲ 477% vs 2024

Debts

Low

€ 137,266

▲ 26% vs 2024

KC PHARMA from Mol, company number BE0479334705, closed financial year 2025 with a result of € 115,605 after tax. For that financial year KC PHARMA recorded a gross margin of € 158,741 and equity of € 736,030. Compared with financial year 2024, the result moved from € 20,026 to € 115,605. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.

What happened at KC PHARMA?

What happened at KC PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 115,605 (▲ 477% vs 2024). Source: NBB ↗
  • KATHLEEN CROUX became a director. NBB
  • New establishment in Mol. KBO
  • Start of the company according to the CBE. KBO

In short

From € 13,953 profit in 2021 to € 115,605 profit in 2025.

Paid € 77,666 in corporate taxes since 2021.

Best year ever: 2025, with € 115,605 profit.

Paid out € 3,360 in dividends to the owners in total.

A new publication or filing at KC PHARMA? We notify you, reason included.

Follow KC PHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

KATHLEEN CROUX
KC PHARMA

Behind KC PHARMA is KATHLEEN CROUX. KATHLEEN CROUX is also behind Stebofisc and TOMKAT.

See the full network in the app

Directors

According to the 2025 annual accounts

KATHLEEN CROUX

Director

Also active at: Stebofisc, TOMKAT

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Leeuwerikheide 86

2400 Mol

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

Details

Company number
0479.334.705
VAT number
BE 0479.334.705
Registered office
Leeuwerikheide 86, 2400 Mol
Names & denominations
KC PHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
16 January 2003
Peppol
Active · Active since 16 Jun 2026
Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Activiteiten van holdings

Managementactiviteiten van holdings

Holdings

Frequently asked questions

What is the enterprise number of KC PHARMA?
The enterprise number of KC PHARMA is BE0479334705.
What is the address of KC PHARMA?
The registered office of KC PHARMA is located at Leeuwerikheide 86, 2400 Mol.
When was KC PHARMA founded?
KC PHARMA was founded on 16 January 2003.
What is the main activity of KC PHARMA?
The main activity of KC PHARMA is "Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies" (NACE code 70200).
Does KC PHARMA have a website?
No website is currently known for KC PHARMA.
How much profit did KC PHARMA make in 2025?
KC PHARMA posted a profit after taxes of € 115,605 in financial year 2025.
What is the revenue of KC PHARMA?
As a small company, KC PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 158,741.
Where can I find the annual accounts of KC PHARMA?
KC PHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of KC PHARMA?
According to the 2025 annual accounts, the directors of KC PHARMA are: KATHLEEN CROUX.
Who owns KC PHARMA?
Behind KC PHARMA is KATHLEEN CROUX. KATHLEEN CROUX is also behind Stebofisc and TOMKAT.